Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
GenBioPro Sues FDA To Keep Generic Mifepristone Available; Supreme Court Delays Its Decision
Apr 20 2023
•
By
Brenda Sandburg
GenBioPro asks court to prevent FDA from taking enforcement action against its generic mifepristone • Source: Shutterstock
More from US FDA
More from Agency Leadership